introduction {#Introduction}
============

Voltage-gated N-, P/Q-, and R-type Ca channels mediate the presynaptic Ca influx that triggers exocytosis of neurotransmitters ([@B23]; [@B71]), and modulation of these Ca channel types through G protein--dependent pathways is a major mechanism of presynaptic inhibition ([@B70]; [@B41]). G protein--dependent modulation of Ca channels may also be influential in the dynamic regulation of membrane excitability in neuronal soma and dendrites ([@B39]). Inhibition of neuronal Ca channels can occur through a variety of membrane-delimited and cytosolic pathways ([@B34]). Inhibition via membrane-delimited pathways develops rapidly, within 1 s of agonist binding to receptors ([@B37]; [@B68]; [@B76]), whereas channel modulation via cytosolic pathways is considerably slower ([@B49]; [@B2]). An interesting property of membrane-delimited Ca channel inhibition is its transient relief by brief, strong depolarizations, a phenomenon known as prepulse facilitation ([@B25]; [@B35]). Facilitation of G protein--inhibited Ca channels can also be induced by trains of action potentials ([@B9]; [@B52]), indicating that sustained electrical firing could relieve presynaptic inhibition in vivo ([@B70]). It was recently demonstrated that membrane-delimited inhibition of Ca channels is effected by Gβγ subunits ([@B33]; [@B36]), and in vitro biochemical experiments have shown that Gβγ can bind to specific regions of the α1 subunits that compose N-, P/Q-, and R-type Ca channels ([@B15]; [@B58]; [@B74]). Such direct interactions are thought to form the molecular basis for membrane-delimited Ca channel inhibition.

Regulators of G protein signaling (RGS)^1^ proteins function as GTPase-accelerating proteins (GAPs) for certain classes of heterotrimeric G protein α subunits ([@B19]; [@B3]). Recent studies have demonstrated that RGS proteins bind to Gα subunits and increase their GTPase activity up to 100-fold, apparently by stabilizing the transition state for GTP hydrolysis ([@B4]; Tessmer et al., 1997; [@B63]). All known mammalian RGS proteins contain a highly conserved core domain of ∼120 amino acids ([@B16]; [@B65]) that is sufficient for binding to certain Gα subunits and for stimulating their GTPase activity in vitro ([@B16]; [@B18]; [@B26]; [@B57]). Point mutations or small deletions within this domain can destroy the ability of RGS proteins to function as GAPs ([@B21]; [@B57]; [@B50]).

Although the in vitro biochemical properties of RGS proteins have been fairly well characterized, relatively little is known about their functions in living cells. However, given the large number (\>19) of distinct mammalian RGS proteins that have been identified to date ([@B3]), it seems reasonable to expect that RGS proteins participate widely in G protein-- dependent pathways. Indeed, because the intrinsic rate of GTP hydrolysis by Gα subunits is too slow (two to five per minute; [@B5]) to account for the kinetics of some G protein--mediated events in nature, GAPs such as RGS are probably essential components of many signaling processes. As one example, RGS9 was recently identified as the GAP for Gαt in retinal rods ([@B32]) and cones ([@B13]), where it is thought to enable rapid termination of the visual phototransduction cascade ([@B60]). Many RGS proteins are expressed in tissue-specific fashion within the brain ([@B30]), suggesting their involvement in specialized neuronal functions.

Previous studies have shown that exogenous RGS proteins can significantly alter the behavior of G protein-- gated inward rectifier K (GIRK) channels. Surprisingly, RGS proteins accelerate the activation and deactivation of agonist-dependent GIRK currents without altering current amplitudes or steady state dose--response relationships ([@B20]; [@B61]). These effects of RGS proteins are paradoxical because the mechanism most likely to account for accelerated GIRK current kinetics (i.e., an increased rate of Gβγ sequestration by Gα-GDP) would also be expected to lower steady state Gβγ concentrations, thereby reducing GIRK current amplitudes and shifting the dose--response curve to higher agonist concentrations ([@B20]), neither of which is observed. Thus, the mechanisms by which RGS proteins influence ion channel function are not well understood.

Here we examine whether RGS proteins can modulate the receptor-mediated inhibition of N-type Ca channels. These voltage-gated channels perform essential functions in neurosecretion and other neuronal activities, and they are strongly inhibited by activated G proteins. We find that coexpression of RGS3T, RGS3, or RGS8 shifts the steady state dose--response curve to higher agonist concentrations, thereby attenuating the G protein--dependent inhibition of N-type channels at submaximal agonist concentrations. Coexpression of RGS3T also changes the kinetics of N-type channel modulation by slowing channel reinhibition after a facilitating prepulse and by speeding channel recovery from receptor-mediated inhibition after agonist removal. RGS proteins thus modify the amplitudes as well as the kinetics of N-type Ca channel inhibition. These results suggest that RGS proteins may significantly influence synaptic transmission and other physiological processes involving G protein--modulated, voltage-gated Ca channels.

materials and methods {#MaterialsMethods}
=====================

Cell Culture and Transfection
-----------------------------

Human embryonic kidney (HEK293) cells (American Type Culture Collection) were maintained under standard conditions. The culture medium contained 90% DMEM, 10% fetal bovine serum, and 50 μg/ml gentamicin. Every 2--3 d, the cells were briefly trypsinized and replated onto 12-mm round glass coverslips. Transfections were by CaPO~4~ precipitation (CellPhect Kit, Pharmacia LKB Biotechnology, Inc.). Control cells were transfected with expression plasmids encoding Ca channel α1B (rabbit brain; [@B27]), α2 (rat brain; [@B40]), and β3 (rabbit brain; [@B69]) subunits at 0.5 μg cDNA each per dish, human (m2) muscarinic receptor ([@B54]) at 0.025 μg cDNA per dish, and human CD8 protein (59565; American Type Culture Collection) or jellyfish enhanced green fluorescent protein (EGFP; Clontech) at 0.05 μg per dish. RGS-expressing cells were transfected with the above plasmids plus expression vectors encoding human RGS3 or RGS3T ([@B11]) or rat RGS8 ([@B61]) protein at 0.25 μg cDNA per dish. Successfully transfected cells were visually identified by labeling with 4.5-μm diameter paramagnetic beads coated with anti--CD8 antibody (Dynal Corp.) or by green fluorescence under ultraviolet illumination. Labeled cells were selected for electrophysiological analysis.

Expression Plasmids and Mutant Construction
-------------------------------------------

α1B was in the expression vector pKCRH2 ([@B48]), α2 was in pMT2 (Genetics Institute), β3 was in pcDNA3 (Invitrogen Corp.), RGS3 and RGS3T were in pCR3.1 uni (Invitrogen Corp.), RGS8 was in pCI (Promega Corp.), m2 receptor was in pRK5. RGS3T is generated from an alternative start codon located at nucleotides 940--942 within the RGS3 coding sequence, and it thus lacks the first 313 amino acids of RGS3 (see Fig. [2](#F2){ref-type="fig"} B; [@B22]; [@B11]). The deletion mutant ΔRGS8 was constructed by digesting pCI-RGS8 with AvrII and TfiI, the over-hanging ends were filled-in using T4 DNA polymerase, and the plasmid was recircularized using T4 DNA ligase. In ΔRGS8, nucleotides 167--478 of the coding sequence of RGS8 have been excised without altering the reading frame, as confirmed by nucleotide sequencing. As a consequence of this deletion, amino acid residues 57--160 are missing from the translated ΔRGS8 protein.

A cDNA construct ("RGS8 core") encoding the conserved RGS domain was made by PCR-amplifying nucleotides 133--516 from the coding sequence of RGS8 ([@B61]). The forward primer was 5′-GCGCGCAAGCTTACCACCATGCTCTCCACAGAAGAAGCGACG-3′ and the reverse primer was 5′-CGCCGCGGATCCCAGCAGATCTAAGTACATTTTGGACCT-3′. The amplified product was sequenced and found to be identical to the core domain of RGS8 (Saitoh et al., 1998). The coding sequence of EGFP (nucleotides 616--1329) was amplified from pEGFP-C3 using the forward primer 5′-GCGGCGGGATCCGTCAGCAAGGGCGAGGAGCTGTTC-3′ and the reverse primer 5′-GCGGCGGAATTCCTACTTGTACAGCTCGTCCATGCCGAG-3′. The RGS8 core and EGFP amplification products were digested with HindIII/BamHI and BamHI/EcoRI, respectively, and ligated together into the HindIII/EcoRI sites of pcDNA3.1+. The resulting plasmid (RGS8 core-EGFP) encodes methionine followed by the conserved core domain of RGS8 (amino acid residues 45--172; [@B61]), fused to the amino terminus of EGFP. The original start codon of EGFP was mutated (by the forward primer) to prevent its independent translation. The other RGS proteins (RGS3T, RGS3, RGS8, and ΔRGS8) were subcloned into the appropriate version of pEGFP (C1, C2, or C3) such that the RGS protein was fused in-frame to the carboxyl terminus of EGFP. In each case, the composition of the chimeric or mutant plasmid was confirmed by restriction digests and nucleotide sequencing.

Voltage-Clamp Recordings
------------------------

Large-bore patch pipettes were pulled from 100-μl borosilicate micropipettes (53432-921; VWR Scientific Products) and filled with a solution containing (mM) 155 CsCl, 10 Cs~2~EGTA, 4 Mg-ATP, 0.32 Li-GTP, and 10 HEPES, pH 7.4 with CsOH. Aliquots of the pipette solution were stored at −80°C, kept on ice after thawing, and filtered at 0.22 μm immediately before use. Pipette tips were coated with paraffin to reduce capacitance, and then fire-polished; filled pipettes had d.c. resistances of 1.0--1.5 MΩ. The bath solution contained (mM) 145 NaCl, 40 CaCl~2~, 2 KCl, and 10 HEPES, pH 7.4 with NaOH. Residual pipette capacitance was compensated in the cell-attached configuration using the negative capacitance circuit of the amplifier. No corrections were made for liquid junction potentials. Carbachol (CCh) or CdCl~2~ was dissolved directly in the bath solution; application of these substances was by bath exchange or by local superfusion using a pressurized macropipette positioning within 3 mm of the cell under study. Temperature (20--22°C) was continuously monitored using a miniature thermocouple placed in the recording chamber.

Ca currents were recorded using the whole-cell patch-clamp technique ([@B31]). The steady holding potential was −90 mV. Unless otherwise noted, step depolarizations to various test potentials were delivered every 10 or 15 s; these stimulation rates were sufficiently low that cumulative inactivation of the N-type Ca current was minimized. Currents were filtered at 2--10 kHz using the built-in Bessel filter (four-pole low pass) of an amplifier (Axopatch 200A or 200B; Axon Instruments) and sampled at 10--50 kHz using a Digidata 1200 analogue-to-digital board installed in a Gateway 486 or Pentium computer. The pCLAMP software programs Clampex and Clampfit (v. 6.0.3) were used for data acquisition and analysis, respectively. Curve fits and figures were made using the software program Origin (v. 5.0). Linear cell capacitance (*C*) was determined by integrating the area under the whole-cell capacity transient, evoked by clamping from −90 to −80 mV with the whole-cell capacitance compensation circuit of the amplifier turned off. The average value of *C* was 23 ± 1 pF (mean ± SEM, *n* = 139 cells). Series resistance (*R* ~S~) was calculated as τ ~\*~(1/*C*), where τ was the time constant for decay of the whole-cell capacity transient. The average values of τ and *R* ~S~, measured before electronic compensation, were 73 ± 4 μs and 3.0 ± 0.1 MΩ, respectively (*n* = 139). When appropriate, τ and *R* ~S~ were reduced by 35--80% using the series resistance compensation circuit of the amplifier. Maximal Ca current amplitudes, measured at the time of peak inward current, were 1.74 ± 0.17 nA (*n* = 139; test potential +30 mV); thus, voltage errors were typically \<5 mV. For example, in 77 cells for which compensated *R* ~S~ was known, the maximum voltage error was 2.4 ± 0.3 mV. The d.c. resistance of the whole-cell configuration was routinely \>1 GΩ. All currents were corrected for linear capacitance and leakage currents using −P/6 or −P/4 subtraction. Statistical comparisons were by two-tailed, unpaired *t* tests (two groups) or by one-way analysis of variance (three or more groups), with *P* \< 0.05 considered significant.

results {#Results}
=======

RGS3T Attenuates the Receptor-mediated Inhibition of N-type Ca Channels
-----------------------------------------------------------------------

To determine whether RGS proteins can influence the G protein--dependent modulation of voltage-gated Ca channels, we examined the receptor-mediated inhibition of N-type Ca currents in the presence or absence of coexpressed RGS3T protein. Fig. [1](#F1){ref-type="fig"} shows whole-cell currents recorded from HEK293 cells expressing cloned N-type Ca channels (composed of transfected α1B, α2, and β3 subunits) and muscarinic (m2) receptors. Exposure to 1 μM carbachol (CCh) produced a rapid (within 1--2 s) and substantial inhibition of the N-type Ca current. This inhibition was mediated by exogenous m2 receptors, as CCh had no effects in cells not transfected with receptor cDNA (data not shown). During inhibition with CCh, N-type currents displayed slowed activation ([@B45]; [@B66]) and current--voltage relationships that were shifted to positive potentials by ∼10 mV compared with currents recorded from the same cells before CCh exposure (Fig. [1](#F1){ref-type="fig"} B). The CCh-inhibited currents were facilitated by prepulses to +100 mV (see Fig. [4](#F4){ref-type="fig"}), demonstrating that a substantial fraction of the inhibition was voltage dependent ([@B1]). These characteristics suggest that inhibition of N-type channels by activated m2 receptors occurred, at least in part, through a membrane-delimited pathway ([@B34]).

The same concentration of CCh (1 μM) also inhibited the N-type Ca current in cells transfected with RGS3T protein (Fig. [1](#F1){ref-type="fig"}). However, the magnitude of inhibition was significantly smaller than in control cells. Thus, in RGS3T-expressing cells, 1 μM CCh reduced the N-type current to 36.4 ± 3.2% (*n* = 6; test potential, +30 mV) of its initial amplitude before CCh exposure, whereas in control cells not transfected with RGS3T the N-type current was reduced to 21.1 ± 3.6% (*n* = 9) of the initial amplitude (*P* ≤ 0.01). These results demonstrate that RGS3T can attenuate the receptor-mediated inhibition of N-type Ca channels.

Effects of Other RGS Proteins
-----------------------------

To determine whether other RGS proteins could also attenuate Ca channel inhibition, we tested RGS3 and RGS8. Exposure to 1 μM CCh reduced the Ca current in RGS3-expressing cells to 47.0 ± 8.8% (*n* = 6; test potential, +30 mV) of the initial amplitude, and in RGS8-expressing cells the Ca current was reduced to 39.3 ± 4.6% (*n* = 6). These magnitudes of inhibition are statistically indistinguishable from that measured in cells expressing RGS3T (*P* = 0.6). For comparison, in control cells not transfected with RGS protein, the N-type Ca current was reduced to 21.5 ± 1.4% (*n* = 56) of its initial amplitude (Fig. [2](#F2){ref-type="fig"} A). Thus, expression of RGS3 or RGS8 also attenuated Ca channel inhibition.

The above experiments were performed using cells that had been simultaneously cotransfected with separate expression plasmids encoding Ca channel α1B, α2, and β3 subunits, m2 receptors, CD8 or EGFP, and one kind of RGS protein. In these experiments, we assumed that cells expressing measurable N-type Ca currents and m2 receptors (as evidenced by CCh-induced inhibition of the Ca current) also expressed the transfected RGS protein. Although this assumption is reasonable, the effects of RGS might have been underestimated if our data included measurements from cells not expressing transfected RGS. To address this potential problem, we constructed chimeric cDNAs encoding fusions of EGFP with RGS3T, RGS3, and RGS8, which allowed us to visually confirm their expression in individual cells. As summarized in Fig. [2](#F2){ref-type="fig"} A, the magnitude of Ca current inhibition in cells expressing EGFP-RGS fusion proteins was comparable with that in cells transfected with wild-type RGS proteins. These results suggest that cells included in our analysis did indeed express the transfected RGS proteins and also that fusion of EGFP to RGS does not interfere with its biological activity.

The Conserved RGS Core Domain Is Necessary and Sufficient for Attenuation of Ca Channel Inhibition
--------------------------------------------------------------------------------------------------

All mammalian RGS proteins contain a conserved core domain of ∼120 amino acids ([@B16]; [@B65]) that binds to Gα and has GAP activity in vitro ([@B16]; [@B18]; [@B57]; [@B26]). Even small deletions within the core domain of RGS proteins destroy their ability to act as GAPs ([@B57]). To examine the role of the core domain in N-type Ca channel inhibition, we constructed two mutant RGS proteins (Fig. [2](#F2){ref-type="fig"} B). In one mutant (ΔRGS8), the majority of the core domain (amino acid residues 57--160) was deleted from RGS8 without altering the reading frame of the remaining protein. The other mutant (RGS8 core) consisted of the conserved core domain of RGS8 (amino acid residues 45--172). Unambiguous identification of cells expressing the RGS8 core mutant was made possible by fusing it to EGFP.

As shown in Fig. [2](#F2){ref-type="fig"} A, expression of ΔRGS8 failed to attenuate the receptor-mediated inhibition of N-type current. Thus, in cells transfected with ΔRGS8, the Ca current was inhibited to 23.8 ± 2.3% (*n* = 12) of its initial amplitude by 1 μM CCh. A similar result was obtained in cells expressing ΔRGS8 fused to EGFP, where 1 μM CCh reduced the current to 16.4 ± 1.2% (*n* = 10) of its initial amplitude. These levels of Ca current inhibition are not different from that observed in control cells (*P* = 0.27), indicating that the core domain of RGS8 is required for its effect on Ca channels.

In contrast, cells expressing the RGS8 core domain exhibited the same levels of Ca current inhibition as cells expressing full-length RGS proteins (Fig. [2](#F2){ref-type="fig"} A). Thus, 1 μM CCh reduced the N-type current in cells expressing RGS8 core EGFP to 35.1 ± 2.6% (*n* = 10) of its initial amplitude, which is indistinguishable (*P* = 0.3) from the inhibition in cells expressing full-length RGS3T, RGS3, or RGS8. This result is significant because it indicates that the RGS core domain is sufficient for its effects on N-type Ca channel inhibition. Additionally, this finding is consistent with the possibility that the GAP activity of RGS proteins accounts for their influence on G protein--mediated Ca channel modulation.

RGS Proteins Shift the Dose--Response Curve to Higher Agonist Concentrations
----------------------------------------------------------------------------

The results presented in Figs. [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"} indicate that RGS proteins attenuate receptor-mediated inhibition of N-type Ca channels during exposure to a single concentration (1 μM) of CCh. To determine whether this effect is due to a shift in the dose--response relationship, we measured Ca current inhibition during exposure to a wide range (0.1 nM--50 μM) of agonist concentrations. As expected, increasing concentrations of CCh caused a progressive inhibition of N-type Ca current (Fig. [3](#F3){ref-type="fig"} A). Importantly, inhibition did not desensitize during the CCh exposures used in our experiments (1--2 min) and it was fully reversible upon CCh washout (Fig. [3](#F3){ref-type="fig"} B).

Fig. [3](#F3){ref-type="fig"} C shows the steady state dose--response curves for control and RGS-expressing cells. Because the average Ca current inhibition at any given CCh concentration did not differ significantly among cells expressing RGS3T, RGS3, or RGS8 (P \> 0.3), data from these three groups were pooled to obtain a single average value of Ca current inhibition at each CCh concentration, and these average values were fit with a logistic equation (see Fig. [3](#F3){ref-type="fig"}, legend) that provided an estimate of the concentration of CCh producing half-maximal inhibition (EC~50~). In RGS-expressing cells the estimated EC~50~ was 153 nM, nearly 10-fold higher than the EC~50~ in control cells (18 nM). Thus, coexpression of RGS protein shifted the dose--response relationship of N-type Ca channel inhibition to ∼10-fold higher CCh concentrations. The fact that inhibition in control cells reached maximal levels at 1 μM CCh, whereas maximal inhibition in RGS-expressing cells required higher concentrations, suggests that Ca current inhibition saturates at lower CCh concentrations than m2 receptor occupancy.

The Decay of Prepulse Facilitation Is Slower in the Presence of RGS
-------------------------------------------------------------------

Membrane-delimited inhibition of N-type Ca channels seems to be attributable to Gβγ rather than Gα subunits ([@B33]; [@B36]; but see Diversé- Pierluissi et al., 1997). The RGS-dependent shift in the dose--response curve (Fig. [3](#F3){ref-type="fig"} C) suggests that the concentration of inhibiting G proteins, presumably Gβγ, was lower in RGS-expressing cells than in control cells during a given level of receptor activation. To test this possibility, we measured the decay of prepulse facilitation in both groups. It is thought that prepulse facilitation reflects the voltage-dependent relief of inhibition; Gβγ subunits are thought to dissociate from Ca channels when the channels change their shape in response to depolarization. Upon repolarization, facilitation decays at an exponential rate ([@B35]), presumably as Gβγ subunits reassociate with channels and reestablish inhibition ([@B43]; [@B8]; [@B29]; [@B24]). The decay of facilitation (i.e., reinhibition) can be measured by varying the interval between the facilitating prepulse and a subsequent test depolarization (see Fig. [4](#F4){ref-type="fig"} B). The fact that the decay of facilitation can be adequately described by a single exponential function is consistent with the idea that rebinding of a single Gβγ dimer is sufficient to reestablish inhibition ([@B75]). Previous studies have shown that the rate at which facilitation decays is proportional to the magnitude of Ca current inhibition ([@B29]; [@B24]), suggesting that the rate of reinhibition is proportional to Gβγ concentration. This idea is supported by the dependence of reinhibition rate upon intracellular Gβγ concentration ([@B75]).

Prepulse facilitation and reinhibition can be represented by a simple two-state model (Scheme I). During a prepulse to +100 mV, Gβγ should dissociate from Ca channels (i.e., *k* ~off~ should dominate) and reassociation should be minimal (i.e., *k* ~on~ should be very small). Upon repolarization to −90 mV, Gβγ subunits should overwhelmingly reassociate with Ca channels, and inhibition should be reestablished with a rate of *k* ~on~ \[Gβγ\] + *k* ~off~. At −90 mV, *k* ~off~ is expected to be very small and can thus be ignored. If *k* ~on~ is similar in control and RGS- expressing cells, any differences in the rates of reinhibition should primarily reflect differences in \[Gβγ\]. By this logic, if Gβγ concentrations are lower in RGS-expressing cells, then reinhibition should proceed more slowly than in control cells. The results presented in Fig. [4](#F4){ref-type="fig"}, A and B, support this prediction: the time constant for decay of facilitation was 40.5 ± 5.8 ms (*n* = 9) in RGS3T-expressing cells vs. 22.7 ± 1.7 ms (*n* = 12) in control cells (*P* \< 0.005). The slower reinhibition in the presence of RGS3T is consistent with lower Gβγ concentrations during a given level of m2 receptor activation.

In contrast to the decay of facilitation, neither the voltage dependence of facilitation (Fig. [4](#F4){ref-type="fig"} C) nor the relationship between facilitation and prepulse potential (Fig. [4](#F4){ref-type="fig"} D) were altered by coexpression of RGS3T. Because these latter measurements primarily reflect the voltage-dependent dissociation of Gβγ subunits from Ca channels, they are not expected to depend upon Gβγ concentration.

As shown in Fig. [4](#F4){ref-type="fig"}, similar magnitudes of prepulse facilitation were obtained for N-type Ca currents in control and RGS3T-expressing cells. Upon first consideration, this result may seem at odds with the different magnitudes of receptor-mediated inhibition in control vs. RGS-expressing cells (e.g., Fig. [2](#F2){ref-type="fig"} A). However, there are at least two reasons why inhibition and prepulse facilitation might not agree quantitatively. First, rapid reinhibition of Ca channels after the prepulse will tend to reduce the amplitude of P2 currents; reinhibition will be fastest and will cause the largest underestimation of facilitation for the most strongly inhibited currents (i.e., those in control cells). Second, some of the inhibition produced by CCh is apparently voltage independent and therefore not relieved by a prepulse ([@B44]).

RGS Proteins Speed the Recovery of Ca Channels from Inhibition
--------------------------------------------------------------

In the case of GIRK channels, the most prominent effect of exogenous RGS proteins is to accelerate the kinetics of agonist-dependent macroscopic currents ([@B20]; [@B61]). To investigate whether RGS proteins are capable of altering the kinetics of Ca channel modulation, we monitored the recovery of N-type channels from inhibition. Representative experiments are illustrated in Fig. [5](#F5){ref-type="fig"}. The time required for recovery from receptor-mediated inhibition was measured as the interval between CCh washout and return of the N-type current to 90% of its final amplitude (*t* ~90~). After washout of 1 μM CCh, the average value of *t* ~90~ was 15.8 ± 2.5 s (*n* = 12) in control cells, whereas it was only 8.0 ± 1.2 s (*n* = 12) in cells expressing RGS3T (*P* = 0.011). A similar difference was also obtained using a much lower (20 nM) concentration of CCh; under these conditions, *t* ~90~ was 12.3 ± 2.8 s (*n* = 6) in control cells and 4.1 ± 0.4 s (*n* = 5) in RGS3T-expressing cells (*P* = 0.027). These results indicate that coexpression of RGS3T significantly speeds the recovery of N-type Ca channels from receptor-mediated inhibition. As shown in Fig. [5](#F5){ref-type="fig"} C, recovery of the N-type current from block by 0.5 mM Cd was complete within ∼2 s, demonstrating that our measurement of *t* ~90~ was not limited by the rate of solution exchange.

discussion {#Discussion}
==========

RGS Proteins Attenuate the Magnitude of Ca Channel Inhibition
-------------------------------------------------------------

Our motive in performing the present study was to determine whether RGS proteins could play significant roles in the G protein--dependent modulation of neuronal Ca channels. We have found that coexpression of RGS3T, RGS3, or RGS8 significantly attenuates N-type Ca channel inhibition produced by activation of G protein--coupled muscarinic (m2) receptors. This effect of RGS proteins results primarily from a shift in the steady state dose--response relationship of Ca channel inhibition to ∼10-fold higher agonist concentrations. That RGS proteins should produce such a shift is perhaps not surprising considering their remarkable GAP activity. Nevertheless, a shift in the dose--response curve is noteworthy because previous studies have found that expression of RGS1, RGS3, RGS4, or RGS8 fails to shift the dose--response relationship of GIRK currents ([@B20]; [@B61]). Interestingly, the three different RGS proteins that we examined (RGS3T, RGS3, and RGS8) shifted the dose--response curve by the same amount and therefore attenuated Ca current inhibition to very similar degrees (Fig. [2](#F2){ref-type="fig"} A). The equivalent effects of RGS3, RGS3T, and RGS8 may indicate that structural differences among these three proteins are not relevant to their function in HEK293 cells. However, subtle differences in the biological activities of RGS3T, RGS3, and RGS8 might not have been apparent if these proteins were each expressed at saturating levels in our experiments.

A rightward shift in the dose--response curve, produced by GTPase-activating proteins, is not without precedent. For example, [@B6] and [@B7] found that PLC-β1, which is a GAP as well as an effector for Gαq, shifted the dose-- response curve of GTP hydrolysis to ∼10-fold higher CCh concentrations. Similarly, [@B73] observed that coexpression of RGS4 shifted the dose--response curve for activation of mitogen-activated protein kinase to higher agonist concentrations. Taken together, these results obtained with PLC-β1 and RGS proteins suggest that GAPs could be expected to produce a rightward shift in the dose--response curve.

RGS Proteins Alter the Kinetics of Ca Channel Modulation
--------------------------------------------------------

We also find that RGS proteins can change the kinetics of Ca channel modulation. Thus, the facilitation produced by a depolarizing prepulse lasted significantly longer in RGS-expressing cells than in control cells (Fig. [4](#F4){ref-type="fig"} B). Experimentally, the decay of prepulse facilitation can be slowed by reducing the level of receptor activation ([@B24]) or by coexpressing a protein (e.g., βARK1 peptide) that is able to bind and sequester Gβγ subunits ([@B14]). Because the decay of facilitation is thought to reflect reassociation of Gβγ with Ca channels, the rate at which facilitation decays should be proportional to the concentration of Gβγ ([@B29]; [@B24]; [@B75]). Our finding that reinhibition of Ca channels is slower in RGS-expressing cells is consistent with the interpretation that Gβγ concentrations were lower in those cells. This interpretation is also in agreement with a previous study demonstrating that the amplitudes of basal, agonist-independent GIRK currents were reduced by coexpression of RGS4 ([@B62]).

Our experiments also indicate that RGS3T speeds the recovery of Ca channels from inhibition (Fig. [5](#F5){ref-type="fig"}). In principle, the recovery time we measured could be determined by a number of steps including unbinding of CCh from m2 receptors, deactivation of receptors, hydrolysis of bound GTP by Gα subunits, and resequestration of Gβγ by GDP-Gα. Of these steps, only hydrolysis of GTP is thought to be rate limiting, and this is the step accelerated by RGS proteins ([@B3]). The faster recovery from inhibition in RGS3T-expressing cells (Fig. [5](#F5){ref-type="fig"}) is likely to result from lower concentrations of Gβγ and also from faster resequestration of Gβγ subunits upon receptor deactivation.

RGS Proteins Appear to Have Different Effects on GIRK and N-type Ca Channels
----------------------------------------------------------------------------

Although GIRK and N-type Ca channels are both modulated by G proteins, the details of their modulation are quite different. For example, GIRK channels are opened and closed by the binding and unbinding, respectively, of Gβγ ([@B59]; [@B67]). Consequently, activation and deactivation kinetics of macroscopic GIRK currents are closely related to the kinetics of Gβγ binding to and unbinding from GIRK channels. In contrast, N-type Ca channels are gated by changes in membrane potential. Binding of Gβγ inhibits the activation of N-type Ca channels by slowing the voltage-dependent translocation of gating charges ([@B38]) and by increasing the first latency of channel opening ([@B10]; [@B53]). Thus, activation and deactivation of Ca channels are primarily voltage-dependent processes that can be rapidly and reversibly modified by interactions with Gβγ.

As previously discussed by [@B20], the effects of RGS proteins on GIRK macroscopic current kinetics could be explained by an increased rate of dissociation (*k* ~off~) of Gβγ subunits from GIRK channels. However, an increased *k* ~off~ should also shift the dose-- response relationship to higher agonist concentrations and decrease the amplitude of GIRK currents at submaximal agonist concentrations. Because neither of these effects were observed ([@B20]; [@B61]), the mechanisms by which RGS proteins influence GIRK channels remain unclear. In comparison, the effects of RGS on N-type Ca channels appear to be somewhat more straightforward because they are entirely consistent with lower Gβγ concentrations resulting from increased GAP activity.

GAP Activity May Account for the Effects of RGS Proteins on N-type Ca Channel Modulation
----------------------------------------------------------------------------------------

In our experiments, N-type Ca channels were inhibited as a consequence of activating G protein--coupled, muscarinic (m2) receptors. When expressed in HEK293 cells, m2 receptors are thought to couple primarily to Gαi ([@B51]). The ability of pertussis toxin to virtually eliminate the response to CCh (Fig. [2](#F2){ref-type="fig"} A) indicates that inhibition via m2 receptors is mediated by members of the Gαi subfamily, and our present data therefore indicate that RGS3T and RGS3 can act as GAPs for Gαi. RGS8 is also a GAP for Gαi, as previously demonstrated by [@B61]. Our finding that the core domain of RGS8 produces the same effect as full-length RGS3T, RGS3, or RGS8 (Fig. [2](#F2){ref-type="fig"}) is consistent with the idea that the GAP activity of RGS proteins is responsible for their effects on Ca channel modulation. However, the core domains of RGS proteins may have other important functions in addition to stimulating GTPase activity. Interestingly, the amino-terminal regions of RGS4 ([@B64]) and RGS16 ([@B12]) are required for these mammalian RGS proteins to substitute for an RGS homologue (Sst2p) in the yeast *Saccharomyces cerevisiae*. Thus, regions of RGS proteins located outside of the conserved core domain may have essential functions in other expression systems, or under cellular conditions different from those of our present experiments.

Relevance of RGS Proteins to Neuronal Ca Channel Function
---------------------------------------------------------

Our present results with RGS proteins may be applicable to other Ca channels besides N-type. For example, P/Q-type Ca channels encoded by α1A subunits ([@B28]; [@B42]; [@B56]) and R-type Ca channels encoded by α1E subunits ([@B55]) can also be strongly modulated through G protein--dependent pathways ([@B47]; [@B72]; [@B70]; [@B46]), and it therefore seems likely that these other Ca channel types will also be influenced by RGS proteins. Because RGS proteins exhibit tissue-specific patterns of expression within the brain ([@B30]), it seems reasonable to postulate that particular RGS proteins might perform specialized roles in specific neuronal pathways. This idea is supported by the recent demonstration that RGS9 is important in visual phototransduction ([@B13]; [@B32]), a highly specialized neuronal event.

Although our present work does not address the physiological importance of RGS proteins in synaptic transmission or other processes involving neuronal Ca channels, our results clearly demonstrate that RGS proteins can significantly alter the G protein--mediated inhibition of N-type Ca channels. Our results obtained in HEK293 cells may therefore be useful in making predictions about the effects of endogenous RGS proteins in neurons. Previous experiments using rapid perfusion systems ([@B37]; [@B47]; [@B76]) have shown that recovery of N- or P-type Ca channels from membrane-delimited inhibition proceeds at a rate very similar to that observed in our HEK293 cells expressing RGS3T (Fig. [5](#F5){ref-type="fig"}). As previously mentioned by [@B76], these rates are significantly higher than the intrinsic rate of GTP hydrolysis exhibited by purified Gαo subunits in vitro, suggesting the involvement of a GAP. In combination with our present results, these previous observations in neurons suggest the hypothesis that endogenous RGS proteins actively speed the recovery of Ca channels from G protein--mediated inhibition. One prediction of this hypothesis is that recovery should be slower in neurons lacking appropriate RGS proteins (i.e., RGS capable of acting as a GAP for the G proteins activated by the receptor). Another prediction is that recovery from inhibition should be slowed by experimentally blocking, inactivating, or depleting endogenous RGS proteins. In future studies, it will be important to test these predictions and attempt to gain further insight into the physiological role(s) of RGS proteins.
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CCh

:   carbachol

EGFP

:   enhanced green fluorescent protein

GAP

:   GTPase-accelerating protein

GIRK

:   G protein--gated inward rectifier K

HEK

:   human embryonic kidney

RGS

:   regulator of G protein signaling

It was recently shown that expression of RGS10 attenuates N-type Ca channel inhibition in rat SCG neurons, and expression of either RGS4 or RGS10 speeds channel recovery from inhibition in neurons overexpressing Gα~z~ proteins. (Jeong, S.-W., and S.R. Ikeda. 1998. G Protein α subunit Gα~z~ couples neurotransmitter receptors to ion channels in sympathetic neurons. *Neuron*. 21:1201--1212.)

![Receptor-mediated inhibition of N-type Ca current is attenuated by coexpression of various RGS proteins. (A) Ca currents were recorded during steady state inhibition with 1 μM CCh. Test pulses to +30 mV were delivered from a steady holding potential of −90 mV. Inhibition is expressed as (current recorded during CCh exposure/current recorded from the same cell immediately before CCh exposure) × 100. EGFP, data obtained exclusively from fluorescent green cells expressing EGFP-tagged RGS proteins. PTX, cells were treated with pertussis toxin (200 ng/ml) in the culture media for 24 h before experiments. The number of cells in each group is indicated in parentheses. *P* indicates the outcome of analysis of variance performed upon the indicated groups. The maximal Ca current densities (measured at +30 mV) were 96 ± 13 pA/pF in control cells (*n* = 56), 76 ± 9 pA/pF in RGS3T-expressing cells (*n* = 55), 41 ± 12 pA/pF in RGS3-expressing cells (*n* = 16), 153 ± 78 pA/pF in RGS8-expressing cells (*n* = 12), 89 ± 27 pA/pF in ΔRGS8-expressing cells (*n* = 22), and 46.5 ± 18.5 pA/pF in cells expressing RGS8 core-EGFP (*n* = 10). There was no correlation between current density and inhibition produced by 1 μM CCh, either in control cells (*r* ^2^ = 0.04, *n* = 56) or in cells expressing RGS3T, RGS3, or RGS8 (*r* ^2^ = 0.009, *n* = 83). (B) Schematic representation of the expressed RGS proteins. Numbers refer to amino acid residues. The approximate location of the conserved RGS core domain is indicated by dark shading. RGS3T lacks the first 313 amino acids of RGS3, but is otherwise identical. ΔRGS8 is missing amino acid residues 57--160, which compose the major portion of the conserved RGS domain. The RGS8 core is the conserved domain of RGS8 (amino acids 45--172).](JGP7806.f2){#F2}

![Coexpression of RGS3T attenuates Ca channel inhibition. (A) Whole-cell Ca currents were recorded from control (left) and RGS3T-expressing (right) cells before and during exposure to 1 μM CCh. The steady holding potential was −90 mV; test potentials are indicated. Data files 98422002, 98422003, 98417009, and 98417011. Linear cell capacitances (C) were 19 (Control) and 34 (RGS3T) pF. Series resistances (*R* ~S~) were 1.4 (Control) and 1.2 (RGS3T) MΩ. (B) Average I--V relationships of Ca currents recorded before (•) and during (○) exposure to 1 μM CCh in nine control cells (left) and six RGS3T-expressing cells (right).](JGP7806.f1){#F1}

![RGS proteins slow the decay of prepulse facilitation. (A) Representative experiments with control and RGS3T-expressing cells during inhibition of the N-type Ca current by 1 μM CCh. Control cell: data file 98528018; *C* = 10 pF; *R* ~S~ = 2.5 MΩ. RGS3T-expressing cell: data file 98522023; *C* = 19 pF; *R* ~S~ = 1.4 MΩ. The voltage protocol is diagrammed in B. The interval between P1 and the prepulse (PP) to +100 mV was fixed at 10 ms; the interval between PP and P2 (Δ*t*) varied from 10 to 110 ms. Successive episodes of this voltage protocol were delivered at 15 s intervals. (B) Slower decay of prepulse facilitation in RGS3T-expressing cells. Symbols represent data averaged from 9--12 cells. The single exponential curves were fit to average values of facilitation (i.e., P2/P1 ratio) at each Δ*t*. The time constant for the decay of facilitation was 17.7 ms for control cells (•) and 42.7 ms for RGS3T-expressing cells (○). Ca currents in control cells were inhibited by 78.3 ± 1.1% (*n* = 12) and those in RGS3T-expressing cells were inhibited by 57.3 ± 3.4% (*n* = 9); this difference was significant (*P* \< 0.0001; *t* test). (C) The voltage dependence of facilitation is unchanged by expression of RGS3T. The voltage protocol is diagrammed. P1 and P2 varied between 0 and +70 mV; P1, PP, and P2 were each 25 ms in duration; P1-PP and PP-P2 intervals were 10 ms in duration. Symbols represent data averaged from six to nine cells. (D) The dependence of facilitation on prepulse potential is similar in control and RGS3T-transfected cells. Intervals between voltage steps as in C. The amplitude of PP varied from +50 to +150 mV in 10-mV increments. Symbols represent data averaged from six to seven cells. In each panel, error bars indicate ±SEM.](JGP7806.f4){#F4}

![Coexpression of RGS proteins shifts the dose--response curve of Ca channel inhibition to higher CCh concentrations. (A) Representative dose--response experiment in a control cell transfected with α1B, α2, and β3 Ca channel subunits and m2 receptors. Shown are selected Ca currents recorded before (Control) and during exposure to various concentrations of CCh. Data file 97D15003; C = 51 pF; *R* ~S~ = 3.0 MΩ. (B) Plot of peak current amplitudes during a dose--response experiment. Currents were evoked by step depolarizations to +30 mV at 15-s intervals. Applications of various concentrations of CCh are indicated by horizontal bars. Same cell and experiment as in A. (C) Dose--response relationships in control (•) and in RGS-expressing cells (other symbols: ○, RGS3; ▵, RGS3T; □, RGS8). Error bars represent ±SEM for 4--11 cells in each group. The highest CCh concentration used was 50 μM. The dose--response curves represent the following logistic equation: *I* ~Ca~ (% of initial) = (100 − *D*)/\[1 + (\[CCh\]/ EC~50~)*^n^*\], where *D*, the percentage of N-type Ca current that could not be inhibited, is 18.1 (Control) or 25.2 (RGS), and the value of the exponent *n* is 0.76 (Control) or 0.60 (RGS). The curve for RGS-expressing cells was fit to the average Ca current inhibition at each CCh concentration, using pooled data from cells expressing RGS3, RGS3T, or RGS8. The values of EC~50~ were 18 nM (control cells) and 153 nM (RGS-expressing cells).](JGP7806.f3){#F3}
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![RGS3T accelerates the recovery of N-type Ca channels from inhibition. (A) Representative time course for recovery of N-type Ca current in a control cell. Ca currents were evoked by 8-ms step depolarizations to +30 mV, delivered at 1 Hz. The holding potential was −90 mV. The times (in seconds) after CCh (1 μM) washout are indicated to the right of each Ca current waveform. Data file 98410002; *C* = 12 pF; *R* ~S~ = 2.1 MΩ. (B) Recovery in an RGS3T-expressing cell. Data file 98408013; *C* = 30 pF; *R* ~S~ = 1.0 MΩ. (C) Representative time course for recovery of N-type current from Cd block (0.5 mM) in a control cell. Recovery is complete within 2 s. Data file 98319017; *C* = 21 pF; *R* ~S~ = 1.6 MΩ. In these recovery experiments, a puffer pipette constructed from theta tubing was positioned within 3 mm of the cell under study. One barrel of the theta tubing contained CCh or Cd dissolved directly in external solution. The other barrel contained external solution without CCh or Cd. The inflows to both barrels were under positive pressure. By switching between barrels, CCh or Cd could be rapidly applied or washed from the cell under study. Flow of the bath solution was continuous and orthogonal to the puffer pipette.](JGP7806.f5){#F5}
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